PTGS2 and colorectal cancer: Epidemiologic studies have shown that nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, significantly reduce the risk of adenomatous polyps or colorectal cancer, and COX-2 is believed to be the prime target of NSAIDs' action [15].